[HTML][HTML] [68Ga] Ga-PSMA-11 in prostate cancer: a comprehensive review
Imaging of the prostate-specific membrane antigen (PSMA) has become an important tool
for managing patients with recurrent prostate cancer, and one of the most frequently …
for managing patients with recurrent prostate cancer, and one of the most frequently …
Salvage therapy for prostate cancer after radical prostatectomy
More than 40% of men with intermediate-risk or high-risk prostate cancer will experience a
biochemical recurrence after radical prostatectomy. Clinical guidelines for the management …
biochemical recurrence after radical prostatectomy. Clinical guidelines for the management …
Hematologic toxicity profile and efficacy of [225Ac]Ac-PSMA-617 α-radioligand therapy of patients with extensive skeletal metastases of castration-resistant prostate …
Abstract Purpose Actinium-225-labeled prostate-specific membrane antigen ([225Ac] Ac-
PSMA-617) is safe and effective in the treatment of metastatic castration-resistant prostate …
PSMA-617) is safe and effective in the treatment of metastatic castration-resistant prostate …
[HTML][HTML] The role of PSMA PET/CT in the primary diagnosis and follow-up of prostate cancer—a practical clinical review
AR Lisney, C Leitsmann, A Strauß, B Meller… - Cancers, 2022 - mdpi.com
Simple Summary The combination of positron emission tomography (PET)-diagnostics with
ligands binding to the prostate-specific membrane antigen (PSMA) has been a diagnostic …
ligands binding to the prostate-specific membrane antigen (PSMA) has been a diagnostic …
Head-To-Head Comparison of 68Ga-PSMA-11 PET/CT and 99mTc-MDP Bone Scintigraphy for the Detection of Bone Metastases in Patients With Prostate Cancer: A …
G Zhao, B Ji - American Journal of Roentgenology, 2022 - Am Roentgen Ray Soc
Please see the Editorial Comment by Sungmin Woo discussing this article. BACKGROUND.
Bone scintigraphy (BS) using 99mTc-labeled methylene diphospho-nate (99mTc-MDP) …
Bone scintigraphy (BS) using 99mTc-labeled methylene diphospho-nate (99mTc-MDP) …
[HTML][HTML] Primary staging in patients with intermediate-and high-risk prostate cancer: Multiparametric MRI and 68Ga-PSMA-PET/MRI–What is the value of quantitative …
SM Skawran, V Sanchez, S Ghafoor, AM Hötker… - European Journal of …, 2022 - Elsevier
Abstract Purpose Comparing mpMRI and 68 Ga-PSMA-PET/MRI in primary staging of PCa
and investigating the value of quantitative mpMRI-measurements for prediction of …
and investigating the value of quantitative mpMRI-measurements for prediction of …
99mTc-PSMA targeted robot-assisted radioguided surgery during radical prostatectomy and extended lymph node dissection of prostate cancer patients
B Yılmaz, S Şahin, N Ergül, Y Çolakoğlu… - Annals of Nuclear …, 2022 - Springer
Objective The feasibility of tracer production of 99mtechnetium (Tc)-prostate-specific
membrane antigen (PSMA)—I&S sterile cold kit, imaging with single photon emission …
membrane antigen (PSMA)—I&S sterile cold kit, imaging with single photon emission …
[HTML][HTML] Predictors of Bone Metastases at 68Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer (HSPC) Patients with Early Biochemical Recurrence or …
G Rovera, S Grimaldi, S Dall'Armellina, R Passera… - Diagnostics, 2022 - mdpi.com
Prostate-specific-membrane-antigen/positron-emission-tomography (PSMA-PET) can
accurately detect disease localizations in prostate cancer (PCa) patients with early …
accurately detect disease localizations in prostate cancer (PCa) patients with early …
Prostate-specific membrane antigen modulates the progression of prostate cancer by regulating the synthesis of arginine and proline and the expression of androgen …
X Hong, L Mao, L Xu, Q Hu, R Jia - Bioengineered, 2022 - Taylor & Francis
The expression of prostate-specific membrane antigen (PSMA) is strikingly upregulated
during oncogenesis and prostate cancer (PCa) progression, but the functions of this antigen …
during oncogenesis and prostate cancer (PCa) progression, but the functions of this antigen …
Factors predicting metastatic disease in 68Ga-PSMA-11 PET–positive osseous lesions in prostate cancer
LW Chiu, C Lawhn-Heath, SC Behr… - Journal of Nuclear …, 2020 - Soc Nuclear Med
Bone is the most common site of distant metastatic spread in prostate adenocarcinoma.
Prostate-specific membrane antigen (PSMA) uptake has been described in both benign and …
Prostate-specific membrane antigen (PSMA) uptake has been described in both benign and …